Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;12(5):1231-1243.
doi: 10.1038/s41385-019-0188-7. Epub 2019 Jul 11.

IL-22-binding protein exacerbates influenza, bacterial super-infection

Affiliations

IL-22-binding protein exacerbates influenza, bacterial super-infection

Robert N Abood et al. Mucosal Immunol. 2019 Sep.

Abstract

Secondary bacterial pneumonia is a significant complication of severe influenza infection and Staphylococcus aureus and Streptococcus pneumoniae are the primary pathogens of interest. IL-22 promotes S. aureus and S. pneumoniae host defense in the lung through epithelial integrity and induction of antimicrobial peptides and is inhibited by the soluble decoy receptor IL-22-binding protein (IL-22BP). Little is known about the effect of the IL-22/IL-22BP regulatory pathway on lung infection, and it has not been studied in the setting of super-infection. We exposed wild-type and IL-22BP-/- mice to influenza A/PR/8/34 for 6 days prior to infection with S. aureus (USA300) S. pneumoniae. Super-infected IL-22BP-/- mice had decreased bacterial burden and improved survival compared to controls. IL-22BP-/- mice exhibited decreased inflammation, increased lipocalin 2 expression, and deletion of IL-22BP was associated with preserved epithelial barrier function with evidence of improved tight junction stability. Human bronchial epithelial cells treated with IL-22Fc showed evidence of improved tight junctions compared to untreated cells. This study revealed that IL-22BP-/- mice are protected during influenza, bacterial super-infection, suggesting that IL-22BP has a pro-inflammatory role and impairs epithelial barrier function likely through interaction with IL-22.

PubMed Disclaimer

Conflict of interest statement

Disclosures

The authors have no conflicts of interest to report.

Figures

Figure 1.
Figure 1.. The impact of influenza infection on the IL-22 pathway.
C57BL/6 mice were infected with 100 PFU of influenza A/PR/8/34 or PBS for 14 days and lungs were harvested every 2 days post-infection. A – Il22 gene expression in lung tissue (n=4/time point). B – Il22bp gene expression in lung tissue (n=4/time point). C – Il22ra1 gene expression in lung tissue (n=4/time point). * p < 0.05 Significance was tested by one-way ANOVA.
Figure 2.
Figure 2.. IL-22BP−/− mice have improved bacterial clearance and decreased mortality.
C57BL/6 and IL-22BP−/− mice were infected with 100 PFU of influenza A/PR/8/34 or 7 4vehicle for 6 days prior to infection with 5 × 107 CFU MRSA for 24 hours or 104 CFU/mL S. pneumoniae for 48 hours. SA = S. aureus, FS = influenza, S. aureus, F = influenza, FS.pneumo = influenza, S. pneumoniae infection throughout the figures. A – MRSA bacterial colony counts in the lung (n = 7−10). B – Weight loss observed during influenza or super-infection (n = 6−18). C – Influenza, MRSA survival curve (n = 7−10). D – S. pneumoniae bacterial colony counts in the lung (n = 8−9). E – Bacterial dissemination to other organs (n = 3−4). F – Influenza matrix protein gene expression measured by RTPCR (n = 6−8). * p < 0.05 Significance was tested by unpaired t test or one-way ANOVA or Gehan-Brislow-Wilcoxon test. Each experiment was independently performed twice and the data shown are from combined experiments with the exception of the survival curve in panel C and dissemination in panel E that are single representative studies.
Figure 3.
Figure 3.. IL-22BP deficiency decreases inflammation.
C57BL/6 and IL-22BP−/− mice were infected with 100 PFU of influenza A/PR/8/34 or vehicle for 6 days prior to infection with 5 × 107 CFU MRSA for 24 hours or 104 CFU/mL S. pneumoniae for 48 hours. A, B – Total cell count in BAL fluid (n = 6−10). C, D – Differential cell counts in BAL fluid (n = 6−10). E – Protein production of pro-inflammatory cytokines in lung homogenate measured by Lincoplex (n = 4−6). * p < 0.05 Significance was tested by unpaired t test or one-way ANOVA. Each experiment was independently performed twice and the data shown are from combined experiments.
Figure 4.
Figure 4.. Deletion of IL-22BP did not impact monocyte subpopulations in the lung.
C57BL/6 and IL-22BP−/− mice were infected with 100 PFU of influenza A/PR/8/34 or vehicle for 6 days prior to infection with 5 × 107 CFU MRSA for 24 hours. Mouse lungs were homogenized to single cell suspensions and stained for analysis of monocyte populations by flow cytometry. A – Alveolar macrophages. B – Interstitial macrophages. C – Inflammatory monocytes. D – Monocyte derived dendritic cells E – TRAIL positive monocytes (n = 6−8). Data are shown from a single representative study.
Figure 5.
Figure 5.. IL-22BP deficiency alters histopathology during super-infection.
C57BL/6 and IL-22BP−/− mice were infected with 100 PFU of influenza A/PR/8/34 or vehicle for 6 days prior to infection with 5 × 107 CFU MRSA for 24 hours or 104 CFU/mL S. pneumoniae for 48 hours. A, B – Histology score (n = 6−10). C – Representative hematoxylin-eosin staining of lungs 24 hours after MRSA or 48 hours after S. pneumoniae (40x magnification). * p < 0.05 Significance was tested by unpaired t test or one-way ANOVA. Each experiment was independently performed twice and the data shown are from combined experiments.
Figure 6.
Figure 6.. IL-22BP deletion improves airway epithelial barrier function during super-infection.
C57BL/6 and IL-22BP−/− mice were infected with 100 PFU of influenza A/PR/8/34 or vehicle for 6 days prior to infection with 5 × 107 CFU MRSA for 24 hours or 104 CFU/mL S. pneumoniae for 48 hours. A, C – Protein in BAL fluid (n = 4−10). B – Absorbance of Evans Blue dye in BAL fluid (n = 11−14). D – Absorbance of lactate dehydrogenase in BAL fluid (n = 6−10). * p < 0.05 Significance was tested by unpaired t test or one-way ANOVA. Each experiment was independently performed twice and the data shown are from combined experiments, except for panel E which is a single representative study.
Figure 7.
Figure 7.. IL-22BP and IL-22 are important for airway epithelial tight junction integrity.
A,B – Claudin and Tjp1 gene expression measured by RT-PCR in C57BL/6 and IL-22BP−/− mice that were infected with 100 PFU of influenza A/PR/8/34 for 6 days prior to infection with 5 × 107 CFU MRSA for 24 hours (A, n = 8−10) or influenza alone (B, n = 6−9). C – Transepithelial electrical resistance of air-liquid differentiated human bronchial epithelial cells at 0 through 24 hours after inoculation with S. aureus and treatment with IL-22Fc or vehicle (n = 3 independent cultures). D – Immunofluorescence staining of polarized human bronchial epithelial cells treated with IL-22Fc or vehicle for 24 hours. Inset numbers reflect ratio of overlap staining. E – Colocalization of ZO-1 and occluden in cells treated with IL-22Fc for 0–72 hours (n = 3 independent cultures, 6 fields per culture). * p < 0.05 Significance was tested by unpaired t test or two-way ANOVA. Each experiment was independently performed two to three times and the data shown are from combined experiments except for panel D which is a single representative study.
Figure 7.
Figure 7.. IL-22BP and IL-22 are important for airway epithelial tight junction integrity.
A,B – Claudin and Tjp1 gene expression measured by RT-PCR in C57BL/6 and IL-22BP−/− mice that were infected with 100 PFU of influenza A/PR/8/34 for 6 days prior to infection with 5 × 107 CFU MRSA for 24 hours (A, n = 8−10) or influenza alone (B, n = 6−9). C – Transepithelial electrical resistance of air-liquid differentiated human bronchial epithelial cells at 0 through 24 hours after inoculation with S. aureus and treatment with IL-22Fc or vehicle (n = 3 independent cultures). D – Immunofluorescence staining of polarized human bronchial epithelial cells treated with IL-22Fc or vehicle for 24 hours. Inset numbers reflect ratio of overlap staining. E – Colocalization of ZO-1 and occluden in cells treated with IL-22Fc for 0–72 hours (n = 3 independent cultures, 6 fields per culture). * p < 0.05 Significance was tested by unpaired t test or two-way ANOVA. Each experiment was independently performed two to three times and the data shown are from combined experiments except for panel D which is a single representative study.
Figure 8.
Figure 8.. Deletion of IL-22BP results in increased lipocalin 2 expression.
C57BL/6 and IL-22BP−/− mice were infected with 100 PFU of influenza A/PR/8/34 or vehicle for 6 days prior to infection with 5 × 107 CFU MRSA for 24 hours. A – Il22bp expression during single or super-infection (n = 6−10). B – Il22ra1 expression in WT and IL-22BP−/− mice (n = 6−10). C,D – Il17 and Il22 expression during super-infection (n = 7−8). E – IL-10 protein concentration in lung homogenate (n = 4−6). F – AMP expression during influenza single infection or super-infection (n = 4−6). Significance was tested by unpaired t test or two-way ANOVA. Each experiment was independently performed twice and the data shown are from combined experiments.

References

    1. Rolfes MA, Flannery B, Chung J, O’Halloran A, Garg S, Belongia EA et al. Effects of Influenza Vaccination in the United States during the 2017–2018 Influenza Season. Clin Infect Dis 2019. - PMC - PubMed
    1. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58(38): 1071–1074. - PubMed
    1. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198(7): 962–970. - PMC - PubMed
    1. Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar J et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 2010; 177(1): 166–175. - PMC - PubMed
    1. Finelli L, Fiore A, Dhara R, Brammer L, Shay DK, Kamimoto L et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122(4): 805–811. - PubMed

Publication types

MeSH terms